The Politics of Drug Pricing

Conclusion While the industry is not shy, or afraid, of a conversation about drug affordability and access, it wants the focus to be on "spending across the health care system to find solutions that ensure access to high quality, patient-centered care and continue to encourage development of innovative, life-changing medicines."       Related StoriesBoth Houses of Congress Investigating Prescription Drug PricesHide No Harm Act of 2015: includes Criminal Penalties for Failure to Report Potential Danger or HarmMore Trouble for Valeant Pharmaceuticals 
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs